Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms

January 2011
BMC Psychiatry;2011, Vol. 11 Issue 1, p171
Academic Journal
The article focuses on an exploratory analysis related to adjunctive long-acting risperidone in patients with bipolar disorder, who relapse frequently and have active mood symptoms. It is stated that bipolar disorder refers to a serious, lifelong mental illness, which is associated with marked psychosocial disability. The background, methods, results, and conclusions of the study, are discussed.


Related Articles

  • The Borderlands of the Depressive States. Kessell, A. // British Journal of Psychiatry;Sep68, Vol. 114 Issue 514, p1135 

    The article presents three studies concern with the third area of confusion, the border area between the depressive states and the psychoneuroses. In these studies, the classification of depressive state is discussed. Observations of clinical similarities in the descriptions of patients given by...

  • Migraine and Mood: Linked Conditions. Jamieson, Dara G. // Neurology Alert;May2008, Vol. 26 Issue 9, p71 

    Up to 30 million Americans suffer from migraine headaches that compromise quality of life and inhibit productivity. The disability of migraine may be further compounded by co-morbid psychiatric conditions that complicate disease management and lead to worsening health outcomes. These two papers...

  • Concordant response to pharmacotherapy in monozygotic twins with schizoaffective disorder. MARKOVIC, J.; PLESTIC, S.; KOSTIC, J. // European Review for Medical & Pharmacological Sciences;2013, Vol. 17 Issue 23, p3262 

    BACKGROUND: Schizoaffective disorder (SAD) represents one of the most confusing and controversial concepts in psychiatry. Prevalence is less than 1%, but despite that it has a major influence on an individual and community. There is an increased risk for schizophrenia and mood diorders in first...

  • Impact of Risperidone on Seclusion and Restraint at a State Psychiatric Hospital. Chengappa, KN Roy; Levine, Joseph; Ulrich, Richard; Parepally, Haranath; Brar, Jaspreet S; Atzert, Rebecca; Brienzo, Rick; Gopalani, Aziz // Canadian Journal of Psychiatry;Nov2000, Vol. 45 Issue 9, p827 

    Objective: To evaluate the impact of risperidone on seclusion and restraint in patients at a state psychiatric facility, shortly after risperidone's release.Methods: Patients who were in the hospital for at least 3 months prior to receiving risperidone and subsequently received risperidone for...

  • An Open-Label Pilot Study of Risperidone in the Treatment of Methamphetamine Dependence. Meredith, Charles W.; Jaffe, Craig; Yanasak, Elisia; Cherrier, Monique; Saxon, Andrew J. // Journal of Psychoactive Drugs;Jun2007, Vol. 39 Issue 2, p167 

    Psychopharmacological treatments for methamphetamine (MA) dependence have questionable efficacy. Open-label risperidone was evaluated in veterans seeking MA dependence treatment. Participants (N = I I) received four weeks of risperidone. They provided weekly self-reports of substance use, urine...

  • Achieving and Sustaining Remission in Depression and Anxiety Disorders: Introduction. O'Donovan, Claire // Canadian Journal of Psychiatry;Mar2004 Supplement, Vol. 49, p5S 

    Major depressive disorder (MDD) is a prevalent medical condition that is frequently associated with comorbid psychiatric and medical conditions and has a high risk for morbidity and mortality (1). Approximately 8% of adults will experience MDD at some time in their lives, and the 1-year...

  • The Human Cost of Not Achieving Full Remission in Depression. McIntyre, Roger S.; O'Donovan, Claire // Canadian Journal of Psychiatry;Mar2004 Supplement, Vol. 49, p10S 

    Depression is among the most disabling and costly illnesses in the world. Despite good short-term efficacy outcomes in the treatment of depression, long-term outcomes remain disappointing. Depression continues to be missed or underdiagnosed and undertreated, and comorbidities are frequently not...

  • Diagnosis of Mood Disorders. Seligman, Linda; Moore, Bonita Marcus // Journal of Counseling & Development;Sep/Oct95, Vol. 74 Issue 1, p65 

    This article provides an overview of mood disorders according to Diagnostic and Statistical Manual of Mental Disorders (4th ed.) criteria and other relevant information. Differential diagnosis is facilitated through discussion of differences and similarities among mental disorders, age and...

  • Cognitive Reactivity, Suicidal Ideation and Future Fluency: Preliminary Investigation of a Differential Activation Theory of Hopelessness/Suicidality. Williams, J. M. G.; Van der Does, A. J. W.; Barnhofer, T.; Crane, C.; Segal, Z. S. // Cognitive Therapy & Research;Feb2008, Vol. 32 Issue 1, p83 

    The authors investigated whether the re-emergence of hopeless/suicidal cognitions over time can be explained within a differential activation framework. Studies 1 ( N = 146) and 2 ( N = 136) showed that individuals who reported suicidal ideation when depressed in the past had higher scores on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics